Contract Manufacturing

Nelipak announced today that it received International Sustainability and Carbon Certification (ISCC) Plus for its Derry, Northern Ireland facility. ISCC PLUS is a globally recognized standard tracking recycled and bio-based materials through the supply chain. It verifies that companies meet environmental and social standards. Cranston, Rhode Island-based Nelipak manufactures healthcare packaging solutions and offers complementary…

Aragen announced that it received a $100 million investment to support the expansion of its pharmaceutical outsourcing services. Quadria Capital, an Asian healthcare-focused private equity fund, made the investment. This results in the company acquiring a minority stake in Aragen, primarily through a fresh capital infusion. A small portion comes from the sale of shares…

Merck agreed to acquire a vaccine manufacturing facility in Ireland from WuXi, the Irish Foreign Direct Investment Arm (IDA) announced today. IDA Ireland said the move comes as part of long-term plans in Ireland for Merck Sharp & Dohme (MSD), Rahway, New Jersey–based Merck’s Ireland business. The acquisition of the facility, located in Dundalk, brings…

PharmaEssentia has reaffirmed its commitment to creating access to critical interferon therapies amid a reported global shortage. The Burlington, Massachusetts-based company noted a recent reported shortage of Pegasys (peginterferon alfa-2a), a treatment for hepatitis C and B. With concerns growing over drug shortages for other therapies, the company said its established cGMP manufacturing network and…

CellProthera announced a deal with Shonan Kamakura General Hospital (SKGH) to transfer technology to enable cell therapy manufacturing for clinical trials. The memorandum of understanding allows for GMP manufacturing of CD34+ endothelial progenitor cells (EPCs) for autologous therapy clinical trials. Takayuki Asahara of SKGH intends to adopt CellProthera’s StemXpand platform for clinical trials starting next…

Novavax announced today that it signed a definitive agreement to sell a European manufacturing plant to Novo Nordisk for $200 million. The agreement centers around the company’s facility in Bohumil, Czech Republic, about 25 miles outside of Prague. It includes a transfer of assets, including a 150,000-square-foot, state-of-the-art recombinant protein manufacturing facility. That includes support…

GBI Biomanufacturing announced today that it expanded its drug product (DP) services to include automated sterile fill and finish capabilities. Plantation, Florida–based GBI says it can support clients from clinical trials to commercial launch, both for drug products and drug substances. All of this can take place at its Florida plant, delivering advanced and flexible…

Ardena announced today that it received full Good Manufacturing Practice (GMP) approval of its expanded nanomedicine facility in Oss, The Netherlands. The approval enables the pharmaceutical CDMO to conduct GMP manufacturing operations for nanomedicines. It follows a €20 million investment in a state-of-the-art 45,000-square-foot facility offering GMP-compliant Grade C and Grade D cleanrooms designed specifically…

Sekisui Diagnostics announced today that its microbial CDMO business completed construction of a £15.7 million ($20.7 million) drug substance manufacturing capacity expansion. The company completed its cGMP capacity expansion at its U.K. site for clinical-grade drug substance manufacturing. Following appropriate licensure, the expansion can enable manufacturing capabilities for common drug types. Those include enzymes, proteins…

Vitrian announced that it closed a $50 million investment into AmplifyBio and its manufacturing enablement center (AMEC) in Ohio. AmplifyBio, a leading advanced therapy CRO and CDMO, offers a full range of drug development and manufacturing services. The investment, which could scale to $65 million, marks a step toward a larger commitment to support biomanufacturing…